LDN-193189 Mechanism of Action: ALK2 Inhibition in Mesenchymal Stem Cell Research

LDN-193189 MOA:Targeting ALK2/BMP Signaling Pathway for Fibrodysplasia Ossificans Progressiva

🎯 check LDN-193189 product page

LDN-193189 is a potent, ATP-competitive BMP receptor (ALK1/2/3) inhibitor. It affects the BMP/Smad signaling pathway by blocking Smad1/5/8 phosphorylation, effectively inhibiting tumor progression and osteoblast differentiation while promoting stem cell neural differentiation.

Primary Applications and Mechanism of Action